Santos C A, Reis L O, Destro-Saade R, Luiza-Reis A, Fregonesi A
Departamento de Cirugía (Urología), Facultad de Ciencias Médicas, Universidad Estatal de Campinas UNICAMP, São Paulo, Brasil.
Departamento de Cirugía (Urología), Facultad de Ciencias Médicas, Universidad Estatal de Campinas UNICAMP, São Paulo, Brasil; Facultad de Medicina (Urología), Centro de Ciencias de la Vida, Universidad Católica de Campinas PUC-Campinas, São Paulo, Brasil.
Actas Urol Esp. 2014 May;38(4):244-8. doi: 10.1016/j.acuro.2013.09.014. Epub 2014 Mar 14.
To evaluate the possible effects of Tribulus terrestris herbal medicine in the erectile dysfunction treatment and to quantify its potential impact on serum testosterone levels.
Prospective, randomized, double-blind and placebo-controlled study including thirty healthy men selected from 100 patients who presented themselves spontaneously complaining of erectile dysfunction, ≥ 40 years of age, nonsmokers, not undergoing treatment for prostate cancer or erectile dysfunction, no dyslipidemia, no phosphodiesterase inhibitor use, no hormonal manipulation and, if present hypertension and/or diabetes mellitus should be controlled. International Index of Erectile Function (IIEF-5) and serum testosterone were obtained before randomization and after 30 days of study. Patients were randomized into two groups of fifteen subjects each. The study group received 800 mg of Tribulus terrestris, divided into two doses per day for thirty days and the control group received placebo administered in the same way.
The groups were statistically equivalent in all aspects evaluated. The mean (SD) age was 60 (9.4) and 62.9 (7.9), P = .36 for intervention and placebo groups, respectively. Before treatment, the intervention group showed mean IIEF-5 of 13.2 (5-21) and mean total testosterone 417.1 ng/dl (270.7-548.4 ng/dl); the placebo group showed mean IIEF-5 of 11.6 (6-21) and mean total testosterone 442.7 ng/dl (301-609.1 ng/dl). After treatment, the intervention group showed mean IIEF-5 of 15.3 (5-21) and mean total testosterone 409.3 ng/dl (216.9-760.8 ng/dl); the placebo group showed mean IIEF-5 of 13.7 (6-21) and mean total testosterone 466.3 ng/dl (264.3-934.3 ng/dl). The time factor caused statistically significant changes in both groups for IIEF-5 only (P = .0004), however, there was no difference between the two groups (P = .7914).
At the dose and interval studied, Tribulus terrestris was not more effective than placebo on improving symptoms of erectile dysfunction or serum total testosterone.
评估刺蒺藜草药在治疗勃起功能障碍方面的可能效果,并量化其对血清睾酮水平的潜在影响。
前瞻性、随机、双盲和安慰剂对照研究,从100名自发前来抱怨勃起功能障碍的患者中选取30名健康男性,年龄≥40岁,不吸烟,未接受前列腺癌或勃起功能障碍治疗,无血脂异常,未使用磷酸二酯酶抑制剂,未进行激素干预,如有高血压和/或糖尿病应得到控制。在随机分组前和研究30天后获取国际勃起功能指数(IIEF-5)和血清睾酮水平。患者被随机分为两组,每组15名受试者。研究组每天分两次服用800毫克刺蒺藜,共服用30天,对照组以相同方式服用安慰剂。
在所有评估方面,两组在统计学上具有等效性。干预组和安慰剂组的平均(标准差)年龄分别为60(9.4)岁和62.9(7.9)岁,P = 0.36。治疗前,干预组的平均IIEF-5为13.2(5 - 21),平均总睾酮为417.1 ng/dl(270.7 - 548.4 ng/dl);安慰剂组的平均IIEF-5为11.6(6 - 21),平均总睾酮为442.7 ng/dl(301 - 609.1 ng/dl)。治疗后,干预组的平均IIEF-5为15.3(5 - 21),平均总睾酮为409.3 ng/dl(216.9 - 760.8 ng/dl);安慰剂组的平均IIEF-5为13.7(6 - 21),平均总睾酮为466.3 ng/dl(264.3 - 934.3 ng/dl)。时间因素仅使两组的IIEF-5发生了统计学上的显著变化(P = 0.0004),然而,两组之间没有差异(P = 0.7914)。
在所研究的剂量和间隔下,刺蒺藜在改善勃起功能障碍症状或血清总睾酮方面并不比安慰剂更有效。